Dekorationsartikel gehören nicht zum Leistungsumfang.
Sprache:
Englisch
177,95 €*
Versandkostenfrei per Post / DHL
Lieferzeit 1-2 Wochen
Kategorien:
Beschreibung
PART I: Introduction
THE DRUG DISCOVERY PROCESS
Pharmacokinetics - Structure Relationship
The Future of Small-Molecule Drugs
LEAD OPTIMIZATION
What Limits/Reduces Oral Bioavailability?
What Limits/Reduces Plasma Half-Life?
How to Improve bbb-Penetration?
How to Avoid CYP Inhibition/Induction?
How to Avoid Interaction with the HumanEther-'a-go-go-Related Gene (hERG)?
How to Prevent Toxicity?
Examples of PK-Optimization in Animals
PART II: The Pharmacokinetic Properties of Compound Classes
ALKANES
Metabolism
ALKENES AND ALKYNES
Metabolism
ARENES
Metabolism
HALIDES
Fluorine
Chlorine
Bromine
Iodine
Alkylating Agents
AZIDES
NITRO COMPOUNDS
Metabolism
AZO COMPOUNDS
TRIAZENES
NITRATES AND NITRITES
N-NITROSO COMPOUNDS
N-OXIDES
ALCOHOLS
Metabolism
PHENOLS
ETHERS
Metabolism
EPOXIDES
PEROXIDES
THIOLS
THIOETHERS
Metabolism
SULFOXIDES
SULFONES
ALIPHATIC AMINES
Basicity
Metabolism
Rates of N-Dealkylation
QUATERNARY AMMONIUM SALTS
AMIDINES
GUANIDINES, ACYLGUANIDINES, AND BIGUANIDES
Acylguanidines
Biguanides
ANILINES
Metabolism
HYDRAZINES, ACYLHYDRAZINES, AND HYDRAZONES
ALDEHYDES
KETONES
CARBOXYLIC ACIDS
Metabolism
Bioisosteres of Carboxylic Acids
Amino Carboxylic Acids, N-Acyl Amino Acids, and Related Compounds
CARBOXYLIC ESTERS
AMIDES
LACTAMS AND IMIDES
Pyrazolone Antipyretics
Five-Membered Lactams as Nootropics
NITRILES
CARBONATES
CARBAMATES
Carbamates as Hypnotics
UREAS
THIOCARBONYL COMPOUNDS
SULFONIC ACIDS
SULFONIC ESTERS
SULFATES AND SULFAMIC ACIDS
PHOSPHONIC ACIDS
PHOSPHORIC ACID DERIVATIVES
N-(AMINOALKYL)BENZAMIDES, -BENZOATES, AND RELATED COMPOUNDS
ARYLALKYLAMINES
Antihistaminics: History
PHENETHYLAMINES (2-PHENYLETHYLAMINES)
Biological Activity of Phenethylamines
Metabolism
Tetrahydroisochinolines and Related Compounds
AMINOALKYLINDOLES AND INDOLE ALKALOIDS
PHENOTHIAZINES
Metabolism
DIBENZAZEPINES AND RELATED TRICYCLIC COMPOUNDS
3-ARYLOXY-2-HYDROXYPROPYLAMINES (B-ADRENERGIC ANTAGONISTS; 'B-BLOCKERS')
Metabolism
OPIATES
N-(CARBOXYALKYL)-a-AMINO ACID AMIDES (PRILS)
ANILIDES AND AMIDES OF GLYCINE
PEPTIDES, PEPTIDOMIMETICS, AND RELATED OLIGOAMIDES
Peptidomimetics
Thrombin Inhibitors and Related Compounds
OLIGOARYLAMINES, OLIGOARYLAMIDES, OLIGOARYLCARBAMATES, AND OLIGOARYLUREAS
IMIDAZOLES
TRIAZOLES
PYRIDINES, PYRIMIDINES, AND RELATED COMPOUNDS
Proton Pump Inhibitors
QUINOLINES
Tecans
Quinazolines
NUCLEOSIDE ANALOGS
DIHYDROPYRIDINES
ARENESULFONAMIDES
Antibacterials
Diuretics
SULFONYLUREAS
BENZODIAZEPINES
STEROIDS
ANTHRACYCLINES
ARYLACETIC, BENZOIC, AND RELATED CARBOXYLIC ACIDS (NSAIDS)
Salicylates
QUINOLONECARBOXYLIC ACIDS (GYRASE INHIBITORS)
B-LACTAMS
Cephalosporins
PROSTAGLANDIN ANALOGS
SARTANS
STATINS
FOLIC ACID ANALOGS (ANTIFOLATES)
TAXANES
MACROCYCLIC COMPOUNDS
THE DRUG DISCOVERY PROCESS
Pharmacokinetics - Structure Relationship
The Future of Small-Molecule Drugs
LEAD OPTIMIZATION
What Limits/Reduces Oral Bioavailability?
What Limits/Reduces Plasma Half-Life?
How to Improve bbb-Penetration?
How to Avoid CYP Inhibition/Induction?
How to Avoid Interaction with the HumanEther-'a-go-go-Related Gene (hERG)?
How to Prevent Toxicity?
Examples of PK-Optimization in Animals
PART II: The Pharmacokinetic Properties of Compound Classes
ALKANES
Metabolism
ALKENES AND ALKYNES
Metabolism
ARENES
Metabolism
HALIDES
Fluorine
Chlorine
Bromine
Iodine
Alkylating Agents
AZIDES
NITRO COMPOUNDS
Metabolism
AZO COMPOUNDS
TRIAZENES
NITRATES AND NITRITES
N-NITROSO COMPOUNDS
N-OXIDES
ALCOHOLS
Metabolism
PHENOLS
ETHERS
Metabolism
EPOXIDES
PEROXIDES
THIOLS
THIOETHERS
Metabolism
SULFOXIDES
SULFONES
ALIPHATIC AMINES
Basicity
Metabolism
Rates of N-Dealkylation
QUATERNARY AMMONIUM SALTS
AMIDINES
GUANIDINES, ACYLGUANIDINES, AND BIGUANIDES
Acylguanidines
Biguanides
ANILINES
Metabolism
HYDRAZINES, ACYLHYDRAZINES, AND HYDRAZONES
ALDEHYDES
KETONES
CARBOXYLIC ACIDS
Metabolism
Bioisosteres of Carboxylic Acids
Amino Carboxylic Acids, N-Acyl Amino Acids, and Related Compounds
CARBOXYLIC ESTERS
AMIDES
LACTAMS AND IMIDES
Pyrazolone Antipyretics
Five-Membered Lactams as Nootropics
NITRILES
CARBONATES
CARBAMATES
Carbamates as Hypnotics
UREAS
THIOCARBONYL COMPOUNDS
SULFONIC ACIDS
SULFONIC ESTERS
SULFATES AND SULFAMIC ACIDS
PHOSPHONIC ACIDS
PHOSPHORIC ACID DERIVATIVES
N-(AMINOALKYL)BENZAMIDES, -BENZOATES, AND RELATED COMPOUNDS
ARYLALKYLAMINES
Antihistaminics: History
PHENETHYLAMINES (2-PHENYLETHYLAMINES)
Biological Activity of Phenethylamines
Metabolism
Tetrahydroisochinolines and Related Compounds
AMINOALKYLINDOLES AND INDOLE ALKALOIDS
PHENOTHIAZINES
Metabolism
DIBENZAZEPINES AND RELATED TRICYCLIC COMPOUNDS
3-ARYLOXY-2-HYDROXYPROPYLAMINES (B-ADRENERGIC ANTAGONISTS; 'B-BLOCKERS')
Metabolism
OPIATES
N-(CARBOXYALKYL)-a-AMINO ACID AMIDES (PRILS)
ANILIDES AND AMIDES OF GLYCINE
PEPTIDES, PEPTIDOMIMETICS, AND RELATED OLIGOAMIDES
Peptidomimetics
Thrombin Inhibitors and Related Compounds
OLIGOARYLAMINES, OLIGOARYLAMIDES, OLIGOARYLCARBAMATES, AND OLIGOARYLUREAS
IMIDAZOLES
TRIAZOLES
PYRIDINES, PYRIMIDINES, AND RELATED COMPOUNDS
Proton Pump Inhibitors
QUINOLINES
Tecans
Quinazolines
NUCLEOSIDE ANALOGS
DIHYDROPYRIDINES
ARENESULFONAMIDES
Antibacterials
Diuretics
SULFONYLUREAS
BENZODIAZEPINES
STEROIDS
ANTHRACYCLINES
ARYLACETIC, BENZOIC, AND RELATED CARBOXYLIC ACIDS (NSAIDS)
Salicylates
QUINOLONECARBOXYLIC ACIDS (GYRASE INHIBITORS)
B-LACTAMS
Cephalosporins
PROSTAGLANDIN ANALOGS
SARTANS
STATINS
FOLIC ACID ANALOGS (ANTIFOLATES)
TAXANES
MACROCYCLIC COMPOUNDS
PART I: Introduction
THE DRUG DISCOVERY PROCESS
Pharmacokinetics - Structure Relationship
The Future of Small-Molecule Drugs
LEAD OPTIMIZATION
What Limits/Reduces Oral Bioavailability?
What Limits/Reduces Plasma Half-Life?
How to Improve bbb-Penetration?
How to Avoid CYP Inhibition/Induction?
How to Avoid Interaction with the HumanEther-'a-go-go-Related Gene (hERG)?
How to Prevent Toxicity?
Examples of PK-Optimization in Animals
PART II: The Pharmacokinetic Properties of Compound Classes
ALKANES
Metabolism
ALKENES AND ALKYNES
Metabolism
ARENES
Metabolism
HALIDES
Fluorine
Chlorine
Bromine
Iodine
Alkylating Agents
AZIDES
NITRO COMPOUNDS
Metabolism
AZO COMPOUNDS
TRIAZENES
NITRATES AND NITRITES
N-NITROSO COMPOUNDS
N-OXIDES
ALCOHOLS
Metabolism
PHENOLS
ETHERS
Metabolism
EPOXIDES
PEROXIDES
THIOLS
THIOETHERS
Metabolism
SULFOXIDES
SULFONES
ALIPHATIC AMINES
Basicity
Metabolism
Rates of N-Dealkylation
QUATERNARY AMMONIUM SALTS
AMIDINES
GUANIDINES, ACYLGUANIDINES, AND BIGUANIDES
Acylguanidines
Biguanides
ANILINES
Metabolism
HYDRAZINES, ACYLHYDRAZINES, AND HYDRAZONES
ALDEHYDES
KETONES
CARBOXYLIC ACIDS
Metabolism
Bioisosteres of Carboxylic Acids
Amino Carboxylic Acids, N-Acyl Amino Acids, and Related Compounds
CARBOXYLIC ESTERS
AMIDES
LACTAMS AND IMIDES
Pyrazolone Antipyretics
Five-Membered Lactams as Nootropics
NITRILES
CARBONATES
CARBAMATES
Carbamates as Hypnotics
UREAS
THIOCARBONYL COMPOUNDS
SULFONIC ACIDS
SULFONIC ESTERS
SULFATES AND SULFAMIC ACIDS
PHOSPHONIC ACIDS
PHOSPHORIC ACID DERIVATIVES
N-(AMINOALKYL)BENZAMIDES, -BENZOATES, AND RELATED COMPOUNDS
ARYLALKYLAMINES
Antihistaminics: History
PHENETHYLAMINES (2-PHENYLETHYLAMINES)
Biological Activity of Phenethylamines
Metabolism
Tetrahydroisochinolines and Related Compounds
AMINOALKYLINDOLES AND INDOLE ALKALOIDS
PHENOTHIAZINES
Metabolism
DIBENZAZEPINES AND RELATED TRICYCLIC COMPOUNDS
3-ARYLOXY-2-HYDROXYPROPYLAMINES (B-ADRENERGIC ANTAGONISTS; 'B-BLOCKERS')
Metabolism
OPIATES
N-(CARBOXYALKYL)-a-AMINO ACID AMIDES (PRILS)
ANILIDES AND AMIDES OF GLYCINE
PEPTIDES, PEPTIDOMIMETICS, AND RELATED OLIGOAMIDES
Peptidomimetics
Thrombin Inhibitors and Related Compounds
OLIGOARYLAMINES, OLIGOARYLAMIDES, OLIGOARYLCARBAMATES, AND OLIGOARYLUREAS
IMIDAZOLES
TRIAZOLES
PYRIDINES, PYRIMIDINES, AND RELATED COMPOUNDS
Proton Pump Inhibitors
QUINOLINES
Tecans
Quinazolines
NUCLEOSIDE ANALOGS
DIHYDROPYRIDINES
ARENESULFONAMIDES
Antibacterials
Diuretics
SULFONYLUREAS
BENZODIAZEPINES
STEROIDS
ANTHRACYCLINES
ARYLACETIC, BENZOIC, AND RELATED CARBOXYLIC ACIDS (NSAIDS)
Salicylates
QUINOLONECARBOXYLIC ACIDS (GYRASE INHIBITORS)
B-LACTAMS
Cephalosporins
PROSTAGLANDIN ANALOGS
SARTANS
STATINS
FOLIC ACID ANALOGS (ANTIFOLATES)
TAXANES
MACROCYCLIC COMPOUNDS
THE DRUG DISCOVERY PROCESS
Pharmacokinetics - Structure Relationship
The Future of Small-Molecule Drugs
LEAD OPTIMIZATION
What Limits/Reduces Oral Bioavailability?
What Limits/Reduces Plasma Half-Life?
How to Improve bbb-Penetration?
How to Avoid CYP Inhibition/Induction?
How to Avoid Interaction with the HumanEther-'a-go-go-Related Gene (hERG)?
How to Prevent Toxicity?
Examples of PK-Optimization in Animals
PART II: The Pharmacokinetic Properties of Compound Classes
ALKANES
Metabolism
ALKENES AND ALKYNES
Metabolism
ARENES
Metabolism
HALIDES
Fluorine
Chlorine
Bromine
Iodine
Alkylating Agents
AZIDES
NITRO COMPOUNDS
Metabolism
AZO COMPOUNDS
TRIAZENES
NITRATES AND NITRITES
N-NITROSO COMPOUNDS
N-OXIDES
ALCOHOLS
Metabolism
PHENOLS
ETHERS
Metabolism
EPOXIDES
PEROXIDES
THIOLS
THIOETHERS
Metabolism
SULFOXIDES
SULFONES
ALIPHATIC AMINES
Basicity
Metabolism
Rates of N-Dealkylation
QUATERNARY AMMONIUM SALTS
AMIDINES
GUANIDINES, ACYLGUANIDINES, AND BIGUANIDES
Acylguanidines
Biguanides
ANILINES
Metabolism
HYDRAZINES, ACYLHYDRAZINES, AND HYDRAZONES
ALDEHYDES
KETONES
CARBOXYLIC ACIDS
Metabolism
Bioisosteres of Carboxylic Acids
Amino Carboxylic Acids, N-Acyl Amino Acids, and Related Compounds
CARBOXYLIC ESTERS
AMIDES
LACTAMS AND IMIDES
Pyrazolone Antipyretics
Five-Membered Lactams as Nootropics
NITRILES
CARBONATES
CARBAMATES
Carbamates as Hypnotics
UREAS
THIOCARBONYL COMPOUNDS
SULFONIC ACIDS
SULFONIC ESTERS
SULFATES AND SULFAMIC ACIDS
PHOSPHONIC ACIDS
PHOSPHORIC ACID DERIVATIVES
N-(AMINOALKYL)BENZAMIDES, -BENZOATES, AND RELATED COMPOUNDS
ARYLALKYLAMINES
Antihistaminics: History
PHENETHYLAMINES (2-PHENYLETHYLAMINES)
Biological Activity of Phenethylamines
Metabolism
Tetrahydroisochinolines and Related Compounds
AMINOALKYLINDOLES AND INDOLE ALKALOIDS
PHENOTHIAZINES
Metabolism
DIBENZAZEPINES AND RELATED TRICYCLIC COMPOUNDS
3-ARYLOXY-2-HYDROXYPROPYLAMINES (B-ADRENERGIC ANTAGONISTS; 'B-BLOCKERS')
Metabolism
OPIATES
N-(CARBOXYALKYL)-a-AMINO ACID AMIDES (PRILS)
ANILIDES AND AMIDES OF GLYCINE
PEPTIDES, PEPTIDOMIMETICS, AND RELATED OLIGOAMIDES
Peptidomimetics
Thrombin Inhibitors and Related Compounds
OLIGOARYLAMINES, OLIGOARYLAMIDES, OLIGOARYLCARBAMATES, AND OLIGOARYLUREAS
IMIDAZOLES
TRIAZOLES
PYRIDINES, PYRIMIDINES, AND RELATED COMPOUNDS
Proton Pump Inhibitors
QUINOLINES
Tecans
Quinazolines
NUCLEOSIDE ANALOGS
DIHYDROPYRIDINES
ARENESULFONAMIDES
Antibacterials
Diuretics
SULFONYLUREAS
BENZODIAZEPINES
STEROIDS
ANTHRACYCLINES
ARYLACETIC, BENZOIC, AND RELATED CARBOXYLIC ACIDS (NSAIDS)
Salicylates
QUINOLONECARBOXYLIC ACIDS (GYRASE INHIBITORS)
B-LACTAMS
Cephalosporins
PROSTAGLANDIN ANALOGS
SARTANS
STATINS
FOLIC ACID ANALOGS (ANTIFOLATES)
TAXANES
MACROCYCLIC COMPOUNDS
Details
Erscheinungsjahr: | 2012 |
---|---|
Genre: | Chemie, Mathematik, Medizin, Naturwissenschaften, Technik |
Rubrik: | Naturwissenschaften & Technik |
Medium: | Buch |
Inhalt: |
XVI
606 S. |
ISBN-13: | 9783527332267 |
ISBN-10: | 352733226X |
Sprache: | Englisch |
Einband: | Gebunden |
Autor: | Zaragoza Dörwald, Florencio |
Auflage: | 1/2012 |
wiley-vch gmbh: | Wiley-VCH GmbH |
Verantwortliche Person für die EU: | Wiley-VCH GmbH, Boschstr. 12, D-69469 Weinheim, product-safety@wiley.com |
Maße: | 240 x 170 x 36 mm |
Von/Mit: | Florencio Zaragoza Dörwald |
Erscheinungsdatum: | 18.04.2012 |
Gewicht: | 1,324 kg |
Details
Erscheinungsjahr: | 2012 |
---|---|
Genre: | Chemie, Mathematik, Medizin, Naturwissenschaften, Technik |
Rubrik: | Naturwissenschaften & Technik |
Medium: | Buch |
Inhalt: |
XVI
606 S. |
ISBN-13: | 9783527332267 |
ISBN-10: | 352733226X |
Sprache: | Englisch |
Einband: | Gebunden |
Autor: | Zaragoza Dörwald, Florencio |
Auflage: | 1/2012 |
wiley-vch gmbh: | Wiley-VCH GmbH |
Verantwortliche Person für die EU: | Wiley-VCH GmbH, Boschstr. 12, D-69469 Weinheim, product-safety@wiley.com |
Maße: | 240 x 170 x 36 mm |
Von/Mit: | Florencio Zaragoza Dörwald |
Erscheinungsdatum: | 18.04.2012 |
Gewicht: | 1,324 kg |
Sicherheitshinweis